About us We invest to extend and enhance human life Our strategy is to create a diversified portfolio of 15-20 globally leading healthcare companies with a goal, over a rolling 10-year basis, of delivering three to five companies in which we retain a significant ownership position to the point of product approval. We focus on developing treatments for patients by working in close partnership with world-class academic founders and management teams. OUR BUSINESS IN NUMBERS* 12 portfolio companies £618m value of life science portfolio £535m capital pool 14 members of the investment team 79% investment team with PhDs/MDs 17 portfolio company board seats Building the next generation of global leaders We do this by founding, building and funding companies to turn exceptional science into transformational treatments to patients in areas of high unmet need. WHO WE ARE A strong sense of culture and social purpose We invest to extend and enhance human life. We have a strong, entrepreneurial culture, where everyone takes personal ownership for delivering Syncona’s mission. Our culture is underpinned by our values. PURPOSE, CULTURE AND VALUES Driving value creation through strategy We take a long-term approach to building leading life science companies, focusing on maximising value through the cycle. Our fundamental view is that value creation in life science comes by taking products into late development, product approval and, in some cases, beyond. A team of experts The life sciences investment team members have deep technical scientific backgrounds, supplemented by strong commercial experience ranging from venture capital investment to pharmaceutical launch. OUR PEOPLE “Our strategy is clear. Syncona is building a sustainable, diversified portfolio of 15-20 companies over a rolling 10-year period.” MELANIE GEE CHAIR, SYNCONA LTD ALSO IN THIS SECTION Our differentiated model We found, build and fund companies around exceptional science in areas of high unmet medical need, where there is potential to take product to market. FIND OUT MORE Rapid translation of scientific research Our platform enables the rapid translation of scientific research into companies with the potential to be global leaders. FIND OUT MORE A data-driven investment process Our data driven investment process leverages the team’s significant expertise. FIND OUT MORE Founded to make a difference Syncona was co-founded in 2012 by the Wellcome Trust, the premium charitable funder of life sciences in the UK. The business was set up to address the lack of long-term funding in UK life science by creating globally competitive, sustainable companies. FIND OUT MORE Latest company updates 1 / 3 10.11.21 Syncona Interim Results for the six months ended 30 September 2021 OPERATING NEWS SYNCONA 02.11.21 Cambridge Epigenetix Raises $88 Million Series D Financing to Advance Best-in-Class DNA Sequencing Technology Platform OPERATING NEWS SYNCONA 08.04.21 Syncona appoints Kenneth Galbraith as Executive in Residence OPERATING NEWS SYNCONA VIEW ALL NEWS RELATED CONTENT Portfolio Investors *Unless stated all financials at 30 September 2021 Sign-up for company news alerts Get the latest RNS, company news, share price information and results from Syncona RNS ALERTS COMPANY ALERTS Contact Syncona Investment Management Limited 2nd Floor 8 Bloomsbury Street London WC1B 3SR contact@synconaltd.com Explore About us Our people Portfolio Sustainability News and Insights Investors Contact Copyright © Syncona 2021 Accessibility Privacy & cookies Employee privacy notice Third party privacy notice Regulatory publications Modern Slavery Statement Syncona Limited is registered in Guernsey no. 55514, registered office Arnold House, PO Box 273, St Julian’s Avenue, St Peter Port, Guernsey GY1 3RD. Syncona Investment Management Limited is registered in England no. 10497864, 8 Bloomsbury Street, London WC1B 3SR and is authorised and regulated by the FCA. Syncona Limited is managed by Syncona Investment Management Limited. Designed & built by SampsonMay Accept to continue or find out more in our cookie policy. Change settings ACCEPT AND CLOSE